Professor Christie Ballantyne
Disclosure details
Financial disclosure: Grant/Research Support- All significant. (All paid to institution, not individual): Abbott Diagnostic, Akcea, Amgen, Arrowhead, Esperion, Ionis, Merck, New Amsterdam, Novartis, Novo Nordisk, Regeneron, Roche Diagnostic, NIH, AHA, ADA. Consultant- 89Bio, Abbott Diagnostics, Alnylam Pharmaceuticals, Althera, Amarin, Amgen, Arrowhead, Astra Zeneca, Denka Seiken*, Esperion, Genentech, Gilead, Illumina, Ionis, Lilly, Matinas BioPharma Inc, Merck, New Amsterdam*, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche Diagnostic *Significant where noted (>$10,000); remainder modest (<$10,000).Chief, Section of Cardiovascular Research
Director, Center for cardiometabolic disease prevention
Professor of medicine, molecular and human genetics, and integrative physiology
Houston, Texas
